Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02252042
Brief Title: Pembrolizumab (MK-3475) Versus Standard Treatment for Recurrent or Metastatic Head and Neck Cancer (MK-3475-040/KEYNOTE-040)

First Submitted : September 25, 2014
First Submitted that Met QC Criteria : September 25, 2014
First Posted : September 29, 2014 (Estimate)

Results First Submitted : May 4, 2018
Results First Submitted that Met QC Criteria : August 10, 2018
Results First Posted : August 13, 2018

Last Update Submitted that Met QC Criteria : July 28, 2021
Last Update Posted : July 29, 2021